* Teriflunomide (Aubagio) has been approved to treat adults with relapsing multiple sclerosis.
* The drug label carries boxed warnings that teriflunomide can produce hepatotoxicity and that its use during pregnancy can cause birth defects.
Un proyecto de la Biblioteca de la Universidad Complutense de Madrid